Invitation to Annual General Meeting of Shareholders

The Board of Directors of Active Biotech AB (publ) has today issued a
notification of the Annual General Meeting, which is to take place at
17.00 on 29 March 2001 at the Scandic Star Hotel, Glimmervägen 5, in Lund.
The notification is published in today's editions of Sydsvenskan, Svenska
Dagbladet and Post- och Inrikes Tidningar.

ACTIVE BIOTECH AB (PUBL)

THE BOARD OF DIRECTORS

Active Biotech AB is a biotechnics company focusing on research and
development of medicines and vaccines. Our expertise lies in the knowledge
of the human immune defence system. We have a high-quality project
portfolio and financial strength. The most important products and projects
are medicines for multiple sclerosis (SAIK-MS) and cancer (TTS), the SBL
Cholera Vaccine, and Dukoral and ETEC vaccines against tourist diarrhoea.
Active Biotech's turnover was MSEK 280 in 2000.

Active Biotech AB (publ)
P.O. Box 724, SE-220 07 Lund, Sweden
Telephone: +46 46 19 20 00
Telefax: +46 46 19 20 50
E-mail:  

Invitation to Annual General Meeting of Shareholders in Active Biotech AB
(publ)

The shareholders in Active Biotech AB (publ) are hereby invited to attend
the Annual General Meeting of Shareholders to be held at 17.00 on
Thursday, 29 March at the Scandic Star Hotel, Glimmervägen 5, in Lund.

NOTIFICATION

Shareholders, who wish to participate in the Annual General Meeting of
Shareholders, must

both be entered under their own names (not registered as a trustee) in
the register of shareholders maintained by Värdepapperscentralen VPC AB on
behalf of the Company, as of 19 March 2001,

and notify the Company of their intention to participate in the
Annual General Meeting of Shareholders by no later than 4 pm on Friday, 23
March 2001.

Notification of participation in the Annual General Meeting of
Shareholders shall be made in writing to Active Biotech AB (publ), Att:
Susanne Jönsson, P.O. Box 724, SE-220 07 Lund, by telephone on +46 (0)46
19 20 00, by telefax on +46 (0)46 19 20 50 or via e-mail to
 . Upon notification the following information shall
be provided: name, personal identity number/corporate registration number,
address and telephone number, together with numbers and type(s) of shares.

In order to possess the right to participate in the Annual General Meeting
of Shareholders, shareholders whose shares are registered in trust through
a bank's trust department or individual stockbroker, must temporarily
register the shares with VPC in their own name. Such re-registration must
be completed by no later than Monday, 19 March 2001.

Active Biotech

Active Biotech's activity is in the biomedical area. The company focuses on R & D.

View more


  CONTACT  
  • Cecilia Hofvander
  • Manager Corporate Communication
  • 046-19 11 22 
  •  

Related documents

 
 
 
 
Social Media Pitch:
Invitation to Annual General Meeting of Shareholders